Sign In
Buy KVUE
$19.24
-0.0700 (-0.363%)
At Close: Jul 31, 2026
Sanofi to create its own Haleon, Kenvue as its stock price tumbles
03:05am, Friday, 27'th Oct 2023
Sanofi (FRA: SNW), the giant healthcare company, is considering spinning off its consumer health business. In a statement, the management said it was hoping to create a separate company listed in Fran
Kenvue CEO Thibaut Mongon: We feel very good about the strength of our business model
11:40am, Thursday, 26'th Oct 2023
Kenvue CEO Thibaut Mongon joins ‘Squawk on the Street' to discuss the company's latest quarter, their new products in the market, and more.
Kenvue shares lower amid slow start to cold and flu season
07:36am, Thursday, 26'th Oct 2023
Kenvue Inc's shares fell 1.7% in pre-market trading after the company posted in-line third-quarter earnings but tightened its full-year guidance after a slow start to the flu and cold season. The comp
Kenvue's stock slides premarket as company reports slow start to flu and cold season
06:53am, Thursday, 26'th Oct 2023
Kenvue Inc.'s stock KVUE, -1.25% fell 2.4% in premarket trade Thursday, after the company posted in-line third-quarter earnings but tightened its full-year guidance after a slow start to the flu and c
Kenvue reports higher Q3 revenue on self-care products strength
06:37am, Thursday, 26'th Oct 2023
Kenvue on Thursday reported higher third-quarter revenue, owing to strong demand for its self-care and skincare products such as Tylenol and Neutrogena.
Kenvue is one of few IPOs trading cheap relative to long-term value: Lido Advisors' Gina Sanchez
02:28pm, Friday, 20'th Oct 2023
Gina Sanchez, Lido Advisors chief market strategist, joins 'The Exchange' to discuss IPOs performing below their debut prices, defensive IPO names to buy, and what names consumers will be willing to p
Kenvue: Consumer Health Giant's Journey From IPO To Legal Challenges And Beyond
02:17am, Thursday, 19'th Oct 2023
Kenvue Inc., a subsidiary of Johnson & Johnson, is a major player in the consumer health industry with a diverse range of products. The company successfully completed its IPO, generating net proceeds
An IPO Pro Buys More Palantir, Rivian, and Kenvue. It Sold Li Auto.
08:00am, Sunday, 15'th Oct 2023
Renaissance Capital LLC's passive IPO-focused ETFs loaded up on Palantir, Rivian, and Kenvue stock, and exited an investment in Li Auto in the third quarter.
Johnson & Johnson's 3Q earnings in spotlight next week following Kenvue split
02:08pm, Friday, 13'th Oct 2023
Johnson & Johnson (NYSE:JNJ) is slated to report earnings before the market opens on Tuesday in what will be the company's first report since spinning off its consumer health division, Kenvue. For i
7 High-Growth S&P 500 Stocks to Buy Now
01:52pm, Thursday, 12'th Oct 2023
While publicly traded securities that benefit from significant upside potential usually carry a higher-risk profile, with high-growth S&P 500 stocks, you can almost get the best of both worlds. To be
IPOs are out of fashion. Here's what companies are doing instead.
11:39am, Friday, 06'th Oct 2023
While the current deal landscape on Wall Street remains low on M&A, initial public offerings (IPOs), and other transactions, corporate spinoffs are chugging along.
2 Magnificent Dividend Kings to Buy Now
06:00am, Thursday, 05'th Oct 2023
Coca-Cola and J&J both have long track records of increasing dividend payments to shareholders. These companies also offer bright earnings prospects well into the future, thanks to their solid product
Here's Why Kenvue Stock Is (Slightly) Riskier Than It Seems
08:36am, Wednesday, 04'th Oct 2023
Kenvue is a fairly safe stock, thanks to its consistent sales of critical goods. However, it doesn't have many opportunities to expand more rapidly than it is now.
Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?
06:00am, Sunday, 01'st Oct 2023
J&J recently spun off its billion-dollar consumer health business to form Kenvue. Kenvue announced a dividend during its first earnings report as an independent entity.
Is Kenvue Stock Too Pricey to Buy?
09:22am, Saturday, 30'th Sep 2023
Kenvue's shares are pricey because it's expected to be a safe bet for investors. Its growth rate is relatively low for its valuation, at least so far.
